Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Interim Management Statement

23rd Oct 2013 07:00

RNS Number : 1314R
Al Noor Hospitals Group PLC
23 October 2013
 



 

 

Wednesday, 23 October 2013: FOR IMMEDIATE RELEASE

London and Abu Dhabi: Al Noor Hospitals Group Plc. (ANHA.L; the 'Company' or 'Al Noor' or 'Group'), the largest private healthcare service provider in Abu Dhabi, today issues its Interim Management Statement for the period 1 July 2013 to 22 October 2013, including a summary of key financial highlights for the three months to 30 September 2013.

 

Key Financial Highlights for 3 months to 30 September 2013

 

3 months to 30 September

Q3 2013

(US$ m)

Q3 2012

(US$ m)

Growth

Revenue

84.0

75.4

11.4%

Number of revenue generating physicians at 30.9.2013

418

340

(+78) 22.9%

 

 

Highlights

 

· The Group continued to perform in line with the expectation in Q3 2013, demonstrating topline growth and increased patient volumes. Underlying EBITDA margin levels remain as expected.

 

· The number of revenue-generating physicians increased by 78 in the first three quarters and the Group remains confident in achieving its target of hiring 90-100 additional physicians in 2013.

 

· The Group has successfully concluded the purchase agreements for two acquisitions including the 75% acquisition of the Al Madar Clinic in Al Ain City and the 75% acquisition of the Manchester Clinic in Jumeirah, Dubai. The two acquisitions together were valued at US$ 16m.

 

· During the first three quarters, three medical centers have been commissioned at Mamura in Abu Dhabi, Sanaya in Al Ain and Muscat in the Sultanate of Oman. In addition, the Group plans to open two new medical centers by the end of this year in Abu Dhabi as part of its organic growth plan.

 

· The Group continues to remain debt free with a strong net cash position allowing Al Noor to continue exploring further acquisition opportunities. In addition, the Group has a committed USD81.7m working capital and acquisition revolver facility expiring on 21/11/2017 that is unutilized and available for future use.

 

 

Dr. Kassem Alom, CEO, Al Noor Hospitals Group Plc. said:

 

"Trading in the third quarter has been in line with management expectations and we continue to make good progress hiring and retaining our physicians, who are essential to our success. Overall we remain on track to meet our expectations for the full year and continue to view the outlook with confidence."

 

"We have successfully concluded the purchase agreements on two acquisitions comprising; Al Madar Medical Centre, a successful medical centre primarily focused on dentistry and cosmetics in an Emirati neighborhood in Al Ain and Manchester Clinic our first step into the Dubai market."

 

 

 

For enquiries please contact:

 

Al Noor Hospitals Group plc.

Dr Sami Alom +971 2 406 6992

Pramod Balakrishnan +971 2 406 6945

 

Brunswick Group

Jon Coles / Craig Breheny +44 20 7404 5959

Rupert Young / Jeehan Balfaqaih +971 4 446 6270

 

 

Cautionary statement

 

These Interim Results have been prepared solely to provide additional information to

Shareholders to assess the Group's performance in relation to its operations and growth

potential. These are unaudited Interim Results and should not be relied upon by any other party or for any other reason. Any forward looking statements made in this document are done so by the directors in good faith based on the information available to them up to the time of their approval of this report. However, such statements should be treated with caution due to the inherent uncertainties, including both economic and business risk factors, underlying any such forward looking information.

 

 

 

 

 

Overview

 

During the three month period ended 30 September 2013, the Group's revenue increased by 11.4% to US$ 84.0m, compared to the same period in 2012. Top line growth was achieved by strong growth in both in-patient and outpatient volumes, driven by increased demand for quality healthcare in the region and also through the Group's physician hiring programme.

 

The Group has continued to attract highly qualified medical staff during the third quarter. Revenue generating physicians increased from 395 by the end of H1 2013 to 418 by end of Q3 2013, an increase of 23 physicians. The Company is on track with its physician hiring program for the year.

 

All our centres are trading well and EBITDA continues to grow in line with management expectations.

 

 

Acquisitions

 

Al Madar Medical Centre (MMC)

 

Al-Madar Medical Centre is located in the Al Khabisi area in Al Ain City. Al Noor has acquired 75% of MMC for a purchase consideration of US$ 11m. The acquisition of MMC will allow Al Noor to extend specialized dentistry and cosmetic services to its patients in Al Ain. Additionally, most of MMC's patients are Emirati, in line with our objective of serving UAE Nationals.

 

Manchester Clinic

 

Manchester Clinic is located in the Jumeirah area in Dubai. Al Noor has acquired 75% of Manchester Clinic for a purchase consideration of US$ 5m. The clinic is situated in an attractive location in Jumeirah; with access to high income nationals and expatriates. The acquisition of this clinic is our first step into the Dubai healthcare market, in line with our strategy to grow into the wider UAE.

 

 

 

On-going Initiatives

 

The Group plans to start two new Medical Centers by the end of this year in Abu Dhabi as part of its organic growth plan.

 

At the Khalifa Street Hospital, as part of the growth plans the Group plans to take up additional space in the existing building and enhancing the interiors of the premises to improve the patient experience.

 

The Group has also commenced work on a phased implementation of SAP in conjunction with a leading systems integrator. This project is expected to run for the next 36 months with a phased implementation of various modules of SAP.

 

 

Financial position

 

As at 30 September 2013, the Group had US$ 108.5m of cash and bank deposits. The two acquisitions will be completed entirely using the surplus cash available to the group at the time of transaction. The total deal value of the two acquisitions was US$ 16m. Capital expenditure for the first three quarters was US$10.0m.

 

The Group continues to remain debt free and has a committed USD$ 81.7m working capital and acquisition revolver facility that is unutilized and available for future use. There were no other material events or transactions that impacted the Group's financial position during the period.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSELLFLXBFBFBQ

Related Shares:

MDC.L
FTSE 100 Latest
Value9,120.31
Change-18.06